Alphaton Capital Corp (ATON) Stock Price, Quote & News

Company Profile

AlphaTON Capital Corp. operates as a digital asset treasury company. It focuses on building and managing a strategic reserve of The Open Network (TON) tokens and developing the Telegram ecosystem. The company provides public market investors with institutional-grade exposure to the TON ecosystem and Telegram's billion user platform. Its activities cover network validation and staking operations, and development of Telegram-based applications, as well as strategic investments in TON-based decentr...

Industry: Asset Management

Sector: Financial Services

Phone: 302 219 5556

Website: alphatoncapital.com

Address:

Clarence Thomas Building, P.O. Box 4649, Road Town, British Virgin Islands

PDot86 Nov. 13 at 8:02 PM

$ATON Toolet

0 · Reply

Aruns84 Nov. 13 at 6:48 PM

$ATON Why the big drop?

0 · Reply

TimeOffStock Nov. 13 at 2:41 PM

$ATON crazy news and drops. Unreal

0 · Reply

Masonic11 Nov. 13 at 2:53 AM

$ATON $TRNX

1 · Reply

Han1Solo1 Nov. 13 at 2:47 AM

$ATON ready to ride this to the moon!

0 · Reply

arielsg Nov. 12 at 9:08 PM

$ATON

0 · Reply

GenghisGrene Nov. 12 at 5:10 PM

$ATON is this thing running?

0 · Reply

DesertBullTrader Nov. 12 at 12:44 PM

$ATON AlphaTON's Cyncado Therapeutics and Australia's ADDRI to Launch Investigator-Initiated Mesothelioma Clinical Trial of TT-4, Complementing U.S. Plans

0 · Reply

Thestocktraderhubzee Nov. 12 at 12:21 PM

$ATON AlphaTON Announces LOI Between ustralia's Asbestos and Dust Diseases Research Institute And Tarus Therapeutics To Conduct Investigator-Initiated Mesothelioma Clinical Trial of TT-4

0 · Reply

smartmoney43 Nov. 11 at 11:02 PM

$ATON $40 next time!!

0 · Reply

AlphaTON Capital and SingularityNET Join Forces to Accelerate Telegram's Cocoon AI – Growing the Ethical, Decentralized AI Ecosystem

Nov 12, 2025, 7:00 AM EST - 2 days ago

AlphaTON's Cyncado Therapeutics and Australia's ADDRI to Launch Investigator-Initiated Mesothelioma Clinical Trial of TT-4, Complementing U.S. Plans

Nov 11, 2025, 8:34 AM EST - 3 days ago

AlphaTON Capital Accelerates Global Growth with Strategic Appointment of William De'Ath as Chief Partnership Officer

Nov 7, 2025, 7:00 AM EST - 7 days ago

Complete Tumor Regressions Observed in Preclinical Models with Co-administration of Cyncado's A2B and A2A Receptor Antagonists and Cancer Vaccines

Nov 5, 2025, 6:19 AM EST - 9 days ago

AlphaTON Capital to Acquire Premier Crypto Newswire Blockchain Wire, Cementing Dominance in Digital Asset Communications via the Telegram Ecosystem

Nov 3, 2025, 1:00 PM EST - 11 days ago

Brittany Kaiser to Present at SALT London 2025 on DeFi, Tokenization, and Digital Asset Treasuries

Nov 3, 2025, 8:00 AM EST - 11 days ago

AlphaTON Capital Corp Announces Strategic Joint Venture with Pago Pay and with ALT5 Sigma to Launch Crypto-Enabled TON Mastercard

Oct 31, 2025, 12:55 PM EDT - 14 days ago

AlphaTON Capital Kicks Off Global World Tour with Investor Breakfast at Nasdaq MarketSite

Oct 29, 2025, 10:46 AM EDT - 16 days ago

AlphaTON Capital Announces Strategic Investment in GPU Infrastructure to Power Cocoon Decentralized AI Network

Oct 27, 2025, 8:10 AM EDT - 18 days ago

AlphaTON Capital CEO Brittany Kaiser to Speak at “Future of Money, Governance, and the Law” Summit on Capitol Hill, October 30, 2025

Oct 25, 2025, 12:30 PM EDT - 20 days ago

AlphaTON Capital and Cyncado Therapeutics Share New Mesothelioma Data Supporting TT-4's Path to First- Patient Dosing

Oct 22, 2025, 12:45 PM EDT - 23 days ago

AlphaTON Capital Joins Blockchain Game Alliance (BGA)

Oct 22, 2025, 12:00 PM EDT - 23 days ago

AACR Abstract: First Evidence that Selective A2B Receptor Inhibition Lowers PD-L1 Tumor Expression and also Directly Suppresses Mesothelioma Tumor Growth

Oct 20, 2025, 7:00 AM EDT - 25 days ago

Enzo Villani, Chief Investment Officer of AlphaTON Capital, to Speak at the Vatican's 10th Anniversary World Changers Summit

Oct 15, 2025, 8:16 AM EDT - 4 weeks ago

AlphaTON Capital Powers TOKEN2049 “Origins” Hackathon in Singapore

Oct 14, 2025, 6:00 PM EDT - 4 weeks ago

How AlphaTON (ATON) is Funding Cancer Research Through Tokenization

Oct 14, 2025, 7:00 AM EDT - 4 weeks ago

AlphaTON Capital CEO Brittany Kaiser and SkyBridge Capital Founder Anthony Scaramucci Join Schwab Network's Trading 360 to Discuss Crypto Innovation and Cancer Research Funding

Oct 13, 2025, 7:26 AM EDT - 4 weeks ago

AlphaTON Capital Launches AI Vertical with MorpheusAI to Accelerate Agentic AI Development on TON and Telegram

Oct 9, 2025, 8:53 AM EDT - 5 weeks ago

AlphaTON Capital CIO and Executive Chairman Enzo Villani Featured in Live Interview at Nasdaq MarketSite with IPO Edge

Oct 8, 2025, 7:16 AM EDT - 5 weeks ago

AlphaTON Capital and Subsidiary Cyncado Therapeutics Pioneer Convergence of Digital Assets and Oncology Innovation: Exploring Tokenization Framework for Mesothelioma Program as it Advances Toward Q1 2026 First Patient Dosing

Sep 30, 2025, 9:35 PM EDT - 6 weeks ago

Animoca Brands and AlphaTON Capital announce equity and token investments; AlphaTON intends to acquire GAMEE

Sep 30, 2025, 8:00 AM EDT - 6 weeks ago

Health In Tech and AlphaTON Capital Sign Strategic Letter of Intent to Develop HITChain

HIT

Sep 25, 2025, 2:45 PM EDT - 7 weeks ago

AlphaTON Capital Corp Successfully Closes $71 million Financing and Completes Initial TON Token Acquisition

Sep 3, 2025, 12:37 PM EDT - 2 months ago

AlphaTON Capital Corp Launches TON Digital Asset Treasury Strategy for the Telegram Ecosystem

Jul 25, 2025, 4:15 PM EDT - 4 months ago

Portage Biotech Reports Results for Fiscal Year Ended March 31, 2025

Jun 25, 2025, 7:00 AM EDT - 5 months ago

Portage Biotech Regains Full Compliance with Nasdaq Continued Listing Requirements

Jun 9, 2025, 6:00 AM EDT - 5 months ago

Portage Biotech and Compedica Stock-for-Stock Exchange

Apr 28, 2025, 10:37 AM EDT - 7 months ago

Portage Biotech Stock Surges As It Prepares For Human Trial

Apr 28, 2025, 6:00 AM EDT - 7 months ago

Portage Biotech Reports Confirmatory Preclinical Results in Mesothelioma Supporting First-In-Human Trial of PORT-7

Mar 28, 2025, 1:13 PM EDT - 8 months ago

Why Is Portage Biotech Stock Skyrocketing Friday?

Mar 27, 2025, 6:02 PM EDT - 8 months ago

Portage Biotech Shares More Than Double After Results of PORT-7 Tumor Treatment Trial

Mar 12, 2025, 8:00 AM EDT - 8 months ago

Portage Biotech Resumes Enrollment in Final Cohort of Dose Escalation for Port-6 in ADPORT-601 Trial

Feb 12, 2025, 4:15 PM EST - 9 months ago

Portage Biotech Receives Extension of Time to Attain Compliance With Stock Exchange Continued Listing Requirements

Jan 30, 2025, 4:30 PM EST - 10 months ago

Portage Biotech Announces Completion of $2.15 Million Private Financing

Jan 6, 2025, 5:00 AM EST - 11 months ago

Portage Biotech Announce Re-Launch of Adenosine Subsidiary as Independently Managed Company; Appointment of Peter Molloy to Lead New Company

Dec 12, 2024, 4:15 PM EST - 1 year ago

Portage Biotech Announces Receipt of Nasdaq Noncompliance Letter

Nov 26, 2024, 4:05 PM EST - 1 year ago

Portage Biotech Reports Results for Fiscal Quarter Ended September 30, 2024

Apr 12, 2024, 8:01 AM EDT - 1 year ago

Portage Biotech Announces Plans to Expand its Evaluation of Strategic Alternatives

Mar 26, 2024, 8:01 AM EDT - 1 year ago

Portage Biotech Completes Monetization of Intensity Therapeutics (INTS) shares

Feb 28, 2024, 5:10 PM EST - 1 year ago

Portage Biotech Reports Results for Fiscal Quarter Ended December 31, 2023, and Business Update

Jan 4, 2024, 8:00 AM EST - 2 years ago

Portage Biotech Reports Business and Strategic Update

Nov 28, 2023, 4:01 PM EST - 2 years ago

Portage Biotech Reports Results for Fiscal Quarter Ended June 30, 2023, and Business Update

Nov 6, 2023, 8:01 AM EST - 2 years ago

Portage Biotech Presents Updates on its iNKT and Adenosine programs at the Society for Immunotherapy of Cancer's (SITC) 38th Annual Meeting

Sep 29, 2023, 8:00 AM EDT - 2 years ago

Portage Biotech Announces $6.0 Million Registered Direct Offering

Sep 20, 2023, 8:00 AM EDT - 2 years ago

Portage Biotech to Participate in Panel Discussion at the Cantor Global Healthcare Conference

Sep 5, 2023, 8:00 AM EDT - 2 years ago

Portage Biotech Announces Collaboration with Merck to Evaluate Two Next-Generation Adenosine Antagonists in Combination with KEYTRUDA® (Pembrolizumab) in Solid Tumors

Aug 30, 2023, 8:00 AM EDT - 2 years ago

Portage Biotech Reports Results for Fiscal Quarter Ended June 30, 2023 and Business Update

Jul 31, 2023, 4:05 PM EDT - 2 years ago

Portage Biotech Reports Fiscal Year-Ended March 31, 2023 Financial Results and Business Update

PDot86 Nov. 13 at 8:02 PM

$ATON Toolet

0 · Reply

Aruns84 Nov. 13 at 6:48 PM

$ATON Why the big drop?

0 · Reply

TimeOffStock Nov. 13 at 2:41 PM

$ATON crazy news and drops. Unreal

0 · Reply

Masonic11 Nov. 13 at 2:53 AM

$ATON $TRNX

1 · Reply

Han1Solo1 Nov. 13 at 2:47 AM

$ATON ready to ride this to the moon!

0 · Reply

arielsg Nov. 12 at 9:08 PM

$ATON

0 · Reply

GenghisGrene Nov. 12 at 5:10 PM

$ATON is this thing running?

0 · Reply

DesertBullTrader Nov. 12 at 12:44 PM

$ATON AlphaTON's Cyncado Therapeutics and Australia's ADDRI to Launch Investigator-Initiated Mesothelioma Clinical Trial of TT-4, Complementing U.S. Plans

0 · Reply

Thestocktraderhubzee Nov. 12 at 12:21 PM

$ATON AlphaTON Announces LOI Between ustralia's Asbestos and Dust Diseases Research Institute And Tarus Therapeutics To Conduct Investigator-Initiated Mesothelioma Clinical Trial of TT-4

0 · Reply

smartmoney43 Nov. 11 at 11:02 PM

$ATON $40 next time!!

0 · Reply

3xR Nov. 11 at 2:22 PM

$ATON $5 then $10 soon. Maybe a squeeze to $15 or $20 🚀

1 · Reply

Stopcapping Nov. 11 at 11:35 AM

$ATON 15 then 5 lol

0 · Reply

smartmoney43 Nov. 8 at 9:05 PM

$ATON give it a month or 2, itll pop to $10+. Im loading under 3.50

0 · Reply

IggyKoopa Nov. 7 at 10:51 PM

$ATON only here to watch the IP from Tarus OG. Not the ATURD coins pump and dump.

1 · Reply

_www_larval_com_ Nov. 7 at 8:52 PM

$ATON -5%[-15%] $TMCI -4%[-31%] $DTCK -4%[-79%] $LZMH 3%[-2%] $EPSM 3%[-13%] most notable movement into the final minutes of trading.

0 · Reply

DesertBullTrader Nov. 7 at 8:04 PM

$ATON Monday this will be $7+

1 · Reply

BearTamerTrading Nov. 7 at 5:52 PM

🚀 Premarket Power Plays 🔥 $MSGM — Motorsport Games Inc. — Leadership shake-up + strong Q3 financial position have ignited investor optimism. 🔥 $BKYI — BIO-key International, Inc. — Secured a major Middle-East defense-sector biometric/security deployment. 🔥 $MTVA — MetaVia Inc. — Reported Q3 2025 results and clinical updates: first patient dosed in MAD cohort of DA-1726; meaningful waist-and-weight reduction in Phase 1. 🔥 $ATON — AlphaTON Capital Corp. — Announced strategic joint-venture and TON-token treasury moves that underline its play in decentralized-asset exposure. Members were already in position before the volume spike 💪 If you missed it, watch the replay for proof — ⬇️ https://www.youtube.com/live/EfJQpvTzjHk?si=0yayiT_E52SbctqL

1 · Reply

_www_larval_com_ Nov. 7 at 4:47 PM

$ATON has stumbled -5% lower to -15% (~2Mv) a moment ago, follow for more volatility.

0 · Reply

DesertBullTrader Nov. 7 at 4:25 PM

$ATON any chance of back to $6+

0 · Reply

VKv2 Nov. 7 at 4:13 PM

$ATON little bit volume takes this to $5

0 · Reply

fun_acronyms Nov. 7 at 3:26 PM

$TRNX $TRNFQ If only there was a whale sitting on $ATON of cash and contingent milestone payments in shares…

0 · Reply

DancingQueen69 Nov. 7 at 3:00 PM

$ATON Making money is sooooo easy 🥂🥂🥂🥂

0 · Reply

Market Cap	22.35M
Revenue (ttm)	0.00
Net Income (ttm)	-6.77M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	62,800
Avg Vol	1,077,298
Day's Range	N/A - N/A
Shares Out	6.35M
Stochastic %K	5%
Beta	0.20
Analysts	Hold
Price Target	N/A